The present study successfully utilizes a new ADME Rat Expression Bioarray, containing 1040 metabolism-and toxicology-linked genes, to monitor gene expression from the livers of rats treated with carbon tetrachloride (CCl 4 ). Histopathological analysis, hierarchical clustering methods, and gene expression profiling are compared between the control and CCl 4 -treated animals. A total of 44 transcripts were found to be altered in response to the hepatotoxin, 19 of which were upregulated and 25 were downregulated. Some of these gene expression changes were expected and concurred with previously published data while others were novel findings.
INTRODUCTION
Microarray technology allows for simultaneously monitoring changes in expression patterns of thousands of genes within cells or tissues. [1] [2] [3] [4] Microarrays, as developed by Schena et al., 5 have become the method of choice for large-scale gene expression measurement. 6 Recent applications for microarray technology include gene expression profiling for toxicogenomic studies. [7] [8] [9] The application of gene expression analysis to models of chemically induced hepatotoxicity has been successfully used to monitor genes for altered expression during toxic injury and gain insight into the mechanism of action of hepatotoxins. [10] [11] [12] Currently, there are two major platforms of nucleic acid microarrays. The first, commonly referred to as the complementary deoxyribonucleic acid (cDNA) microarray, consists of probes (usually amplified cDNAs or PCR products) attached to a surface such as a nylon membrane or glass substrate. 5, [13] [14] [15] [16] [17] The other, referred to as the oligonucleotide array, utilizes synthetically derived oligonucleotides (oligos) spotted onto a surface via in situ synthesis of oligos [18] [19] [20] [21] [22] [23] or deposition of prefabricated oligos [24] [25] [26] [27] [28] [29] onto the desired substrate. There are several advantages and disadvantages to both commonly used microarray platforms. 1, [29] [30] [31] [32] [33] [34] In general, cDNA microarrays use a multicolor strategy of labeling several different targets, allowing for comparison of relative expression changes among different samples to be performed on a single array. between dyes, all of which can affect differential expression results. 29, 36, 37 Other issues with the cDNA platform include probe generation, quality control, and standardization. Clone generation and PCR amplification must be performed continually, as one has to conduct a new reaction and purification to replenish amplicon supply. Furthermore, sources of DNA and clones require laborious tracking and quality checking. 17, 38 Lastly, cDNA arrays require rigorous standardization methods, and even though universal references are used as controls, the search still continues for improved reference standards. 39 Oligonucleotide arrays are considered to be more reproducible and predictable than cDNA arrays. 40 Therefore, one can use single-color labeling techniques, whereby gene expression comparisons are made by performing ratio analysis between different samples run on independent arrays, with greater confidence. Furthermore, several oligonucleotides can be designed to serve as internal standards used to compare expression results from different experiments. Oligonucleotide probes offer greater specificity than cDNAs or PCR products, in that they can distinguish between closely related members of gene families, discern splice variants, and allow for analysis of single nucleotide polymorphisms (SNPs). 27, 29, 40, 41 When sequence information is available, oligonucleotides can be designed to hybridize specifically to each gene in the target sample. A major advantage of the deposition-type oligonucleotide arrays is that stringent quality control measures, confirming the fidelity and purity of the synthesized oligos, can be performed prior to array manufacturing.
Although these are the two most common types of microarrays, several advancements continue to be made to all types of microarrays, including improvements to array surfaces (glass, silicon, gold, three-dimensional gel matrix), fluorescent labeling, detection methods, number of spots on the arrays (high-density arrays), printing technologies (noncontact and contact), and experimental hybridization procedures. 27, 35, [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] The bioarray used in this study is a new oligonucleotide array, consisting of prequalified oligonucleotides covalently attached via a noncontact dispense method to a threedimensional gel matrix affixed to a glass surface. This paper describes the use of this new oligonucleotide array in a biological validation study involving the treatment of rats with carbon tetrachloride (CCl 4 ), a well-established model of chemically induced hepatotoxicity. 9, 11, 12, 52, 53 The goal of this study was to show that this novel bioarray, which has already been demonstrated to meet or exceed current industry standards and specifications, 54 could be successfully employed to measure expected gene expression changes. It was hypothesized that the results of histopathological and gene expression analysis of hepatic tissue from CCl 4 -treated animals would confirm and/or reject previously published gene expression findings, as well as identify other target genes of interest, either not tested or missed by previously published studies that used other microarray platforms or more traditional methods of gene expression analysis.
RESULTS

Histopathology
The histopathology data indicated minimal to mild triaditis, and minimal to no extramedullary hematopoiesis in the control animals from day 0. Additionally, one animal presented extracapsular hemorrhaging. In contrast, the control animals from days 4, 7, and 14 exhibited minimal to mild hepatocellular fatty change, minimal to no extramedullary hematopoiesis, and mild to no triaditis. Also, two animals in the day 4 control group exhibited swollen endothelium of centrilobular sinusoids, and one animal in the day 14 control group exhibited sinusoidal inflammation. Animals in the day 4 CCl 4 -treated group displayed moderate to marked hydropic degeneration, mild to marked individual centrilobular hepatocyte necrosis, moderate to marked hepatocellular fatty change, and increase of mitotic figures. Animals in the day 7 CCl 4 -treated group showed mild to moderate hepatocellular fatty change. Finally, animals in the day 14 CCl 4 -treated group exhibited minimal to moderate hepatocellular fatty change, and less significant and inconsistent lesions than the other treated groups. The differential physiological states of these animals, induced by the hepatotoxin, occurred along with expression changes of some inflammatory, metabolic, and other genes.
The Bioarray
In all cases, scatter plots of same-same hybridizations show that a straight line was fit to each data set and no obvious skewing was detected. The R 2 values did not differ significantly between the 'raw' data as compared to the 'normalized' data plots for all animals. These values ranged from an R 2 of 0.74 to 1.00 and only three of these values were found to be less than 0.90 for both the 'raw' and 'normalized' data sets. The slopes of all lines were close to one. The slopes of the lines that fit to the 'raw' data ranged from 0.38 to 1.59, and those that fit to the 'normalized' data varied less across a tighter range of 0.76 and 1.11. The yintercepts varied between a range of À16,341 and 78,155 for the 'raw' data, and between À0.59 and 2.38 for the 'normalized' data. Figure 1a shows a representative scatter plot of the 'normalized' data from one animal in the day 0 control group.
Intensities of the probes within arrays between each data group were subtracted from one another (array1 À array2). Histograms graphing these differences between each set of arrays among the same animal RNA were plotted and found to be distributed as a bell-shaped curve (data not shown). Some outliers were revealed, which may mean divergence from a normal distribution. However, overall data sets were tightly distributed in all cases about a mean near zero.
Additionally, the variation within each group of signals per gene per animal was examined by calculating coefficients of variation (CV). Identifying the relative standard deviation among the arrays allowed a quantitative estimate of the precision of the array in detecting differential gene expression. 55 The overall average percentage CVs ranged from 11.6 to 29.4% with an average of 16.1% and a median of 14.4%. Figure 1b displays a representative distribution of the percent CV for one animal from the day 7 control group.
Hierarchical clustering, self-organizing maps (SOMs), and ratio analysis were used to analyze differential gene expression. Hierarchical clustering was performed in order to compare the different groups to one another (Figure 2 ), as well as individual genes to one another (data not shown). Figure 2 contains two dendrograms created from complete and single-linkage clustering algorithms. This analysis enabled visualization of the distinct differences between the animals of the day 4 CCl 4 -treated groups and the day 0 control groups against all other groups.
SOMs were used to visualize genes with similar expression dynamics and identify the dominant up-and downregulated genes from one particular group relative to another. Figure 3a shows a profile of the most significantly upregulated genes in the day 4 CCl 4 -treated group relative to all other time points and treatments. These genes were a subset of all genes clustered by the SOM in the original profile and were significantly upregulated because of having a relative expression value larger than 2.0. Figure 3b shows another profile of the most significantly downregulated genes in the day 4 CCl 4 -treated group relative to all other time points and treatments, also a subset of all genes clustered by the SOM in the original profile (supplemental data). These genes were significantly downregulated, having a relative expression value of less than 0.5. As shown in Figure 3 , these altered expression values were only about a three to five-fold change from the control levels. This analysis of the day 4 CCl 4 -treated group compared to all other time points resulted in 16 upregulated and 16 downregulated genes, which represented 2.8% of genes on the array. All the genes determined differentially expressed by the SOM analysis for day 4 are listed in Table 1 , and the expression behavior of these genes between days 7 and 14 are also included.
Ratio analysis was performed in order to identify dominant expression profiles, and the results were depicted using log-log scatter plots. Figure 4a depicts the log-log scatter plot of the median day 4 CCl 4 -treated gene expression values vs the median day 4 control gene expression values. A total of 19 genes were significantly (Po0.05) upregulated (ratio of treated/control larger than 2.0), while 21 genes were significantly (Po0.05) downregulated (ratio of treated/ control less than 0.5), which corresponds to roughly 3.5% of all the genes studied. Figure 4b shows the log-log scatter plot of the median day 7 CCl 4 -treated gene expression values vs the median day 7 control gene expression values. Figure 4c shows the log-log scatter plot of the median day 14 CCl 4 -treated gene expression values vs the median day 14 control gene expression values. Finally, Figure 4d shows the log-log scatter plot of the median of all the gene expression values from the CCl 4 -treated groups pooled together vs the median of the pooled control gene expression values. All genes identified by the ratio analysis method as differentially expressed at day 4 and found statistically significant (two-tailed homoscedastic T-test, a ¼ 0.05) are listed in Table 1 along with their corresponding expression behavior for days 7 and 14.
As depicted in Table 1 , all upregulated genes identified by SOM analysis were also found upregulated by the ratio analysis. Three additional genes were found to be upregulated by the ratio analysis method, but were not identified by SOM analysis. Of the 16 downregulated genes found by SOM analysis, all but four of them were also identified by ratio analysis. Nine additional genes were found downregulated by ratio analysis, but were not found by SOM analysis.
DISCUSSION
The histopathological findings of the animals, which included centrilobular hepatocellular necrosis, an increase of mitotic figures, hydropic degeneration, hepatocellular fatty changes, and inflammation, were expected and concurred with other similar studies involving CCl 4 . 9, [56] [57] [58] The reproducibility tests performed on the bioarray were used to assess data quality and check for consistency with current and accepted industry standards for microarray performance. Replicates that are highly reproducible allow for detection of authentic differential expression over the biological variability among animals. 59 Overall, reproducibility test results were consistent with other acceptable published results. 55, 60 Furthermore, array quality and specification for these studies were consistent with those described by Ramakrishnan et al. 54 for this particular platform.
Only 0.3% of the 'raw' data were identified as outliers and removed. There are several potential causes of outliers in this microarray data. Outliers may occur during the manufacturing process of the arrays resulting in distortions in the array, element irregularities, absence of elements, misaligned elements, and contamination. 61 In the laboratory, outliers can also result from human error, inefficient hybridization, water spots on the slides, etc. Finally, during slide processing and scanning, outliers may also result from the image analysis software as it aligns and extracts intensity values from the arrayed elements. 62 A high-quality microarray will have a small percentage of outliers, which can be removed without disrupting the integrity of the entire data set. Thus, based on the analysis performed, we feel this data set meets the generally accepted definition of a high-quality microarray. Hierarchical clustering, SOMs, and ratio analysis are three of the most reliable and common methods of microarray gene expression analysis. [63] [64] [65] Different analysis methods were used because all analysis methods have their limitations, and the likelihood of identifying all the significant gene expression patterns increases with the more analysis methods performed. 66 Regardless of the algorithm used, the hierarchical clustering techniques (Figure 2 ) revealed a clustering of day 4 CCl 4 -treated and day 0 control animal groups from other animal groups. Using more than one clustering technique served as a helpful tool to filter out the effect of invariant genes that may have been attracted to different clusters. The separate clustering of the day 4 treated animals was a predicted outcome of the experiment layout, and validated the plan to focus on the specific gene expression patterns within that group.
In Table 1 , four of the genes (Atf3, Tage4, C3ar1, Ccnd2), which showed significant changes in gene expression between the control and treated groups, had a majority of values below the negative control threshold in the control groups and values above threshold in the treated day 4 animals. Prior to analysis, data were filtered and outliers were removed; however, no data were removed based on having expression values below threshold. The negative threshold is simply an estimate of the lower limit of detection. In this case, the microarray platform was sensitive enough to identify these low-expressing genes. If values had been removed from the data set that were below threshold, these four genes could have been missed. For example, Atf3, a transcription repressor induced during cellular stress, 67 was found to be the most differentially expressed upregulated gene by all analysis methods used in this experiment. For this gene, the expression values for all control samples and treated samples from, days 7 and 14, were near or below the negative control threshold, however, the values of day 4 CCl 4 -treated samples showed a significant roughly six-fold change. The expression pattern observed for this gene was expected and consistent with a previously published study. 68 Several of the genes identified by these analyses were consistent with previously published observations, while others were considered novel findings. A few of these verified genes include the aforementioned Atf3 gene, 68 and the Ip10 gene, which codes for a chemokine known as interferon inducible protein 69 , and has previously been shown to be induced after CCl 4 treatment 70 . The Cyp2c gene codes for the p450 enzyme, CYP2C11, whose activity decreases after CCl 4 administration. 71 CCl 4 -treated rats have been used as models for low levels of CYP2C11 in the liver. 72 Other examples include Lgals3 73, 74 In addition, there were many novel changes in gene expression documented by this study. Many of the observed expression changes for these genes appeared to correlate with the known functional roles of the genes and, in some cases, could be linked with other genes affected by CCl 4 . Some examples include the Ptpro gene, which is a member of the protein tyrosine phosphatases, 79 and has a strong homology to GLEPP1, 80 which has been shown to increase at the time of liver injury. 81 The Cd44 gene family consists of widely distributed cell surface glycoproteins involved in inflammatory responses. 82 The principal carbohydrate ligand of Cd44, hyluronic acid, has been shown to be a useful marker for liver injury induced by CCl 4 in rats. 83 Lastly, even though Cyp3a18 and Cyp3a9 have not been studied with CCl 4 , the family of p450 isozymes to which these genes belong, Cyp3A, has been studied and shown to exhibit alterations to expression levels with various toxins, including CCl 4 . 84, 85 In summary, several differential gene expression patterns were revealed in this study as derived from three of the most common analysis methods for analyzing gene expression data. Similar results were obtained between the analysis methods and most gene expression patterns observed were in agreement with current published knowledge. These facts established confidence in the findings and furthermore demonstrated that this new bioarray platform is a valid tool for use in gene expression studies.
Future work will include RT-PCR assays for verification of genes with results near or below the negative threshold boundary. RT-PCR can also be used to verify the novel findings of dynamic changes in gene expression between control and treated groups. The primary focus of this paper was to investigate the genes differentially expressed one day after CCl 4 administration ceased (day 4 CCl 4 -treated group). Most of the differentially expressed genes followed a pattern of being at control levels, changing significantly at the day 4 treated time point, and then returning to control levels at days 7 and 14 treated time points. However, there were a few genes that were differentially expressed at day 4 and remained elevated or suppressed throughout day 7 and/or 14. Others were at control levels at day 4 treated time point and differentially expressed only in the day 7 and/or day 14 CCl 4 -treated groups. The study of these genes, which were differentially expressed in the recovery time period, may lead to interesting findings of genes involved in regeneration and tissue repair.
MATERIALS AND METHODS
Experimental Design
This study was designed in accordance with pharmaceutical toxicology studies described in the literature. 9, 56 Seven groups consisting of five male Sprague-Dawley rats, 6 weeks of age and weighing between 200 and 225 g at the onset of the study, were divided into one nonvehicle control group (euthanized at day 0 after being fasted for 12 h), three groups of vehicle controls, and three groups of CCl 4 -treated animals. Each rat from these six groups was administered, using intraperitoneal injection, either pure corn oil (vehicle control animals) or CCl 4 dissolved in corn oil (B15% v/v) at a dose level of 1000 mg/kg/day, a level that has been shown to be hepatotoxic but not lethal. 86 Animals were dosed for three consecutive days, subsequently fasted for 1 day, and then euthanized via CO 2 asphyxiation on the 4th, 7th, or 14th day of the study.
The central lobe of each liver was harvested at the time of necropsy, and approximately 1 g was flash frozen by immersion in liquid nitrogen for subsequent RNA extraction. RNA extraction was performed on each animal liver (not pooled across groups) using the TRIzol reagent protocol from GibcoBRL s . The remaining fraction of the liver was placed in 10% formalin. A single representative section was cut from each block, placed on a slide, and stained with hematoxylin & cosin (H&E). These slides were subsequently reviewed and scored by a veterinary pathologist.
Sample Preparation
Total ribonucleic acid (RNA) was quantified by measuring ultraviolet (UV) absorption ratio at 260/280 nm and checked for quality using a Bioanalyzer 2100 (Agilent Technologies, Palo Alto, CA, USA). Preparation of the biotin-labeled complementary RNA (cRNA) target was performed using the BioRobot 9604 (Qiagen, Valencia, CA, USA) and a PTC-225 DNA Engine Tetradt Cycler (MJ Research, Inc., Boston, MA, USA).
Single-stranded cDNA was prepared from 10 mg of total RNA using a T7-(dT)24-oligonucleotide primer and Superscriptt II RNaseH-reverse transcriptase (200 U/ml). Included in this reaction was a mixture of six bacterial RNAs of known concentration for use as positive controls (2.5 pg/ml of araB/ entF, 8.33 pg/ml of fixB/gnd and 25 pg/ml of hisB/leuB). Double-stranded cDNA was then generated with E. coli DNA polymerase I (10 U/ml) and RNase H (2 U/ml). After purification using a Qiagen QIAquick purification kit, the doublestranded cDNA, served as a template to prepare biotinlabeled cRNA via in vitro transcription (IVT), performed in the presence of biotinylated nucleotides. The labeled-cRNA transcripts were purified using RNEasy columns (Qiagen) and assessed for quantity and quality using the same methods described above. Two samples (CCl 4 -treated, day 7, animal number 5 and CCl 4 -treated, day 14, animal number 4) yielded only enough cRNA for one array and were therefore not included in the analysis. This resulted in 33 total animals rather than 35. The biotin-labeled cRNA was then randomly fragmented, by incubating 10 mg of the sample in the presence of magnesium for 20 mins at 941C. This resulted in fragmented target with a size range between 100 and 200 bases.
Hybridization and Scanning
The biotinylated cRNA target was hybridized to two ADMERat Expression Bioarrays (Motorola Life Sciences). For each array, 10 mg of the fragmented target cRNA was added to 260 ml of hybridization buffer, denatured, and then injected into hybridization chambers, sealed, and incubated for 18 h at 371C while shaking at 300 rpm. Each array was then briefly rinsed in TNT Buffer, stained with a 1:500 dilution of Streptavidin-Alexa 647 (Molecular Probes, Eugene, OR, USA), and washed with several TNT and deionized water rinses before being dried with a nitrogen gun. Processed arrays were scanned using an Axon GenePix Scanner and array images were acquired and analyzed using CodeLinkt Expression Analysis Software.
The Bioarray
The ADME Rat Expression Bioarray (Motorola Life Sciences) consists of 1040 single-stranded oligonucleotide probes for interrogation of rat genes linked to metabolism, toxicology (including apoptosis, repair enzymes and cell cycle regulation), absorption, excretion, and xenobiotic metabolism (such as p450 enzymes). Additionally, there are a total of 97 positive and negative controls for each array in the study. The oligos are computer designed and biologically validated to represent a single gene transcript. All oligonucleotides are 30 bases long and are monitored for chemical concentration, quality, and sequence integrity before being spotted on the array. The oligos are spotted in triplicate onto the array by a noncontact piezoelectric mechanism to allow for precise spot location and reproducible dispense volumes. The aqueous polyacrylamide gel matrix, to which the oligos are attached, is a biological environment that enables greater target access to the probes on the array and provides good nucleic acid hybridization kinetics and performance.
Data Preparation
The CodeLinkt Analysis Software (Motorola Life Sciences) gives a total integrated optical density (IOD) value for every hybridization spot, from which a unique background value for each spot is subtracted, resulting in 'raw' data points. There were six 'raw' data points per probe per animal to be examined (as every sample was hybridized to two arrays, and all gene probes on each bioarray are spotted in triplicate).
The 'raw' data for the 1040 probes of interest were imported into MATLAB s (The mathworks, Natick, MA, USA) Rel.12.1 outlier detection and removal. First, the median of each set of six data points was calculated and the absolute value of the difference between each data point and this median was calculated. The median absolute deviation was then determined. A modified z-score (M i ) for each original gene expression value was derived as the absolute difference between the original data point and the median of the set to which it belonged, multiplied by 0.6745 and divided by the median absolute deviation for the set. If a gene expression value in a given set of six values was the largest of the values and its M i was larger than 8.7, it was labeled an outlier and removed from the 'raw' data set. 87 After outlier removal and bioarray quality tests, the resulting data sets were normalized with respect to the median value of all 'raw' data points on a given bioarray. This produced two data sets used for further analysis referred to as the 'normalized' data set. One consisted of the six normalized values for each of the 1040 probes on the bioarray, and the other a single expression value per 1040 probes per treatment group (this was determined by calculating a median of the six normalized values for the probe across each group).
A negative control threshold was used to estimate the lower limits of detection. Each bioarray had 54 negative control probes spotted in triplicate. The negative control threshold was calculated per animal by taking the mean negative control value and adding three standard deviations in order to obtain the 99.7% confidence level.
Bioarray Quality
Reproducibility tests were performed using JMP (SAS, Cary, NC, USA) and Excel (Microsoft, Redmond, WA, USA) software packages on the six data points across all 1040 probes of interest.
Scatter plots of same-gene hybridizations for both the 'raw' and 'normalized' data were created by comparing the six median values across each gene for one array against a second array. Histograms showing the distribution of the differences between the median gene expression values (array1 À array2) among the same animal RNA from both the 'raw' and the 'normalized' data were performed. The individual CV across each gene for each animal was also determined using the 'normalized' data set, by taking the standard deviation across the six data points divided by the mean expression value across the points and multiplying this by 100 to obtain a percent.
Gene Expression Data Analysis
The 'normalized' data set, comprised of one expression value per 1040 probes per treatment group, was imported into Xpression NTI (Informax, Bethesda MD, USA), Genespring (Silicon Genetics, San Jose, CA, USA) and Microsoft Excel in order to perform hierarchical clustering analysis, create SOMs, and generate log-log scatter plots for ratio analysis, respectively.
Hierarchical clustering of the data identified similar gene expression patterns among the control and treatment groups. Clustering was performed by comparing all the control and treated groups (Figure 2 ) as well as by comparing all the individual genes to one another (data not shown). The results were represented in dendrograms, a type of tree diagram whereby groups of genes sharing similar expression profiles are depicted near one another on the tree, and those with different properties are further away. 88 Complete and single linkage hierarchical clustering algorithms were used. The complete linkage algorithm defined the branching of the hierarchical tree by using the largest dissimilarity between an object and one node (or point where the branches in the tree meet) and an object of another node in the hierarchical tree. The single linkage method used the smallest dissimilarity between an object and its node and the other objects that form the node, to define the clusters. 89 Sets of dominant gene expression profiles were generated using SOMs. The clustering analysis program assigned expression values for each gene, which ranged from 0 to 5.0. SOMs were performed with default settings in a 3 Â 3 profile (see supplemental data for 3 Â 3 SOM results). A filter of gene expression values less than 0.5 and greater than 2.0 was used on the day 4 CCl 4 -treated data, in comparison with other control and treated groups, to determine genes that were significantly up-or downregulated and shown in Figure 3 . 24 Ratio analysis was done by comparing the ratio of differential change among the intensity values of the treated animals to their respective controls. Ratios were determined by dividing the median treated value by the respective median control value and then plotted on log-log scatter plots. The groups compared were as follows: day 4 control vs day 4 CCl 4 -treated groups, day 7 control vs day 7 CCl 4 -treated groups, day 14 control vs day 14 CCl 4 -treated groups, and all vehicle controls vs all CCl 4 -treated animals. Any genes with ratios outside 2-fold were considered differentially expressed. Specifically genes with ratios greater than 2.0 were considered upregulated, while genes with ratios less than 0.5 were considered downregulated. A two-tailed homoscedastic T-test was performed between each control and treatment group in order to determine the probability of the two groups being similar. The null hypothesis was rejected for P values less than 0.05. Only those genes that met both criteria of a two-fold ratio difference and a significant P value were reported as differentially expressed by the ratio analysis method.
